Captopril and Venous thrombosis limb - a phase IV clinical study of FDA data

Summary:

Venous thrombosis limb is reported as a side effect among people who take Captopril (captopril), especially for people who are female, 50-59 old, also take Cymbalta, and have Depression.

The phase IV clinical study analyzes which people have Venous thrombosis limb when taking Captopril. It is created by eHealthMe based on reports of 17,289 people who have side effects when taking Captopril from the FDA, and is updated regularly.

What is Captopril?

Captopril has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 17,438 Captopril users. Check the latest studies of Captopril.

What is Venous thrombosis limb?

Venous thrombosis limb (blood clot that forms in a vein in the limb) is found to be associated with 365 drugs and 502 conditions by eHealthMe. Check the latest studies of Venous thrombosis limb.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

17,289 people reported to have side effects when taking Captopril.
Among them, 12 people (0.07%) have Venous thrombosis limb.

Could Captopril cause Venous thrombosis limb?

Among these 12 people:

What is the gender of people who have Venous thrombosis limb when taking Captopril? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Venous thrombosis limb when taking Captopril? *

What are other drugs people take besides Captopril? *

What are other side effects people have besides Venous thrombosis limb? *

Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 11 people, 91.67%
Headache (pain in head): 11 people, 91.67%
Pain: 11 people, 91.67%
Thrombocytopenia (decrease of platelets in blood): 11 people, 91.67%
Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 10 people, 83.33%
Insomnia (sleeplessness): 10 people, 83.33%
Hyperaesthesia: 10 people, 83.33%
Weight Increased: 10 people, 83.33%
Increased Tendency To Bruise (increased tendency to injure the underlying soft tissue or bone): 10 people, 83.33%
Injury: 10 people, 83.33%

What are the existing conditions these people have? *

Stress And Anxiety: 10 people, 83.33%
Pain: 10 people, 83.33%
Neoplasm Malignant (cancer tumour): 10 people, 83.33%
Depression: 10 people, 83.33%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 8.33%
Brain Neoplasm Malignant (brain cancer tumour): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Captopril and have Venous thrombosis limb?

- Check whether Venous thrombosis limb is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Captopril:

Captopril (17,438 reports)

Browse all side effects of Captopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Venous thrombosis limb:

Venous thrombosis limb (365 drugs)

Browse all the conditions that are associated with Venous thrombosis limb:

Venous thrombosis limb (502 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on captopril (the active ingredients of Captopril) and Captopril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.